Group show

Group show

FPJ BureauUpdated: Saturday, June 01, 2019, 03:17 PM IST
article-image

A group exhibition of paintings, graphics & sculptures by four contemporary artists, namely, Bhagyawan Parkar, Milind Varangaonkar, Ravindra Kajari and Pritam Deuskar.

They will be jointly displaying their recent paintings, graphics & sculptures in various mediums and techniques in. It is a splendid endeavor of various artists from vivid regions of our country with diverse backgrounds and cultural vignettes.  Milind Varangaonkar is a realistic artist based in Udaipur-Rajasthan, Deep impression of social life and its norms in that area and surroundings have influenced him considerably. Ravindra Kajari has used oil as medium to adorn his work on canvas with due emphasis on the beauty of nature and its vivid marvels. Pritam Deuskar’s work in graphics using Corex Cut and relevant techniques mostly exemplifies the architectural details of various monuments. Bhagyawan Parkar’s sculptures in fibres, FRP etc mostly illustrate spiritual aspects of eternity and divine blessing from the almighty.

When: Till March 10, 11 am to 7 pm

Where: Nehru Centre Art Gallery (AC), Discovery of India Building, Dr. Annie Besant Road, Worli, Mumbai

Contact:  07798291246 / 09829188713

RECENT STORIES

FLY91 Launches Daily Kochi–Agatti Flights, Announces Expansion To 7 New Regional Stations
FLY91 Launches Daily Kochi–Agatti Flights, Announces Expansion To 7 New Regional Stations
Gold Breaches ₹1.5 Lakh Per 10 Grams Mark; Silver Surges To Record ₹3.23 Lakh Per Kg
Gold Breaches ₹1.5 Lakh Per 10 Grams Mark; Silver Surges To Record ₹3.23 Lakh Per Kg
Investors’ Wealth Erodes By ₹9.86 Lakh Crore As Stock Markets Tumble
Investors’ Wealth Erodes By ₹9.86 Lakh Crore As Stock Markets Tumble
Canada–China Trade Deal Ill-Timed And One-Sided Amid Unresolved Disputes: Report
Canada–China Trade Deal Ill-Timed And One-Sided Amid Unresolved Disputes: Report
Concept Medical Launches Global Trial On Next-Gen Drug-Eluting Stent
Concept Medical Launches Global Trial On Next-Gen Drug-Eluting Stent